SEC Tracker
Get the app

Oric Pharmaceuticals ORIC

ORIC Pharmaceuticals, Inc. amended and restated its 2020 Equity Incentive Plan, effective

Form
8-K
Filed
Importance
Routine
  • Reports an executive or board change (5.02)
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Oric Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Geron GERN public float $861M, Jun 30, 2025
  2. Intellia Therapeutics NTLA public float $869M, Jun 30, 2025
  3. Wave Life Sciences WVE public float $851M, Jun 30, 2025
  4. CorMedix CRMD public float $910M, Jun 30, 2025
  5. Niagen Bioscience NAGE public float $814M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.